Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
Vertex Pharmaceuticals (VRTX) Stock Forecast & Price Target
5,354 Followers
See the Price Targets and Ratings of:
VRTX Analyst Ratings
Moderate Buy
17 Buy
5 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VRTX Stock 12 Month Forecast
Average Price Target
$467.00
▼(-0.90% Downside)
| Highest Price Target$555.00 | Average Price Target$467.00 | Lowest Price Target$325.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Morgan Stanley
Reiterated
06/27/24
Redburn Atlantic
Initiated
06/27/24
William Blair
Reiterated
06/24/24
Bank of America Securities
Assigned
06/24/24
Argus Research
Reiterated
06/17/24
BMO Capital
$480→$500
Buy
6.10%
Upside
Reiterated
05/31/24
Vertex Pharmaceuticals price target raised to $500 from $480 at BMO CapitalVertex Pharmaceuticals price target raised to $500 from $480 at BMO Capital
Oppenheimer
$500
Buy
6.10%
Upside
Assigned
05/10/24
Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Stifel Nicolaus
$430→$420
Hold
-10.88%
Downside
Reiterated
05/08/24
Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX)
Leerink Partners
$511→$529
Buy
12.25%
Upside
Assigned
05/07/24
Vertex Pharmaceuticals price target raised to $529 from $511 at LeerinkVertex Pharmaceuticals price target raised to $529 from $511 at Leerink
Truist Financial
―
Buy
―
Reiterated
05/07/24
Truist Financial Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)
Best Analysts Covering Vertex Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy VRTX and Sell After:
1 Month
3 Months
1 Year
Success Rate
12/12 ratings generated profit
Average Return
+24.06%
assigned a buy rating 2 months ago
Copying David Risinger's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +24.06% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VRTX Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
0
0
0
0
0
Buy
58
41
41
36
41
Hold
22
12
12
9
13
Sell
5
6
6
6
5
Strong Sell
0
0
0
0
0
total
85
59
59
51
59
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
VRTX Financial Forecast
VRTX Stock Forecast FAQ
What is VRTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Vertex Pharmaceuticals’s 12-month average price target is $467.00.
What is VRTX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VRTX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VRTX a Buy, Sell or Hold?
Vertex Pharmaceuticals has a consensus rating of Moderate Buy which is based on 17 buy ratings, 5 hold ratings and 2 sell ratings.
What is Vertex Pharmaceuticals’s price target?
The average price target for Vertex Pharmaceuticals is $467.00. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $555.00 ,the lowest forecast is $325.00. The average price target represents -0.90% Decrease from the current price of $471.25.
The highest analyst price target is $555.00 ,the lowest forecast is $325.00. The average price target represents -0.90% Decrease from the current price of $471.25.
What do analysts say about Vertex Pharmaceuticals?
Vertex Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 24 Wall Streets Analysts.
How can I buy shares of VRTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.